 RICHMOND, Va.--BUSINESS WIRE--Aditxt, Inc. Aditxt, or the Company. Nasdaq: ADTX, a biotech innovation company with a mission to improve the health of the immune system, today announced key executive management changes to support its growth plans. Corinne Pankovcin, who has served as CFO of Aditxt, has been appointed as President and will work closely with the Companys CEO, Amro Albanna, to execute Aditxts business strategy. Thomas J. Farley, who has served as Controller and Principal 